Fluctuating raw material prices mean market knowledge is a must for companies competing in the intermediates and ingredients space according to Granules India.
Quintiles’ decision to hire Accenture’s Tom Pike as its new CEO suggests consulting services will be even more important in the future for the world’s largest CRO.
Royal DSM NV has confirmed that Percivia – its biosimilars joint venture (JV) with Crucell - is to cease in-house product development after failing to agree on future investment and says that job losses are likely.
In-Pharmatechnologist.com has chosen Interphex - the drug industry’s biggest production and processing technology show – as the launch event for our new look, refocused news website.
The SFDA has closed down 10 gel capsule factories and revoked two licenses after finding 23 batches of products tainted with “excessive levels” of the toxic metal chromium.
Indian contract manufacturer Surya Pharmaceutical has received an EDQM Certificate of Suitability (CEP) for an antibiotic API and approval for its Banur plant from Teva.
The American Business Council (ABC) has warned US drugsmakers working in Pakistan to brace themselves for supply chain disruptions as the Government imposes heavy delays on the process used to allocate raw materials to manufacturers.
Battling contract services firm Warnex has repaid debentures through a new financing deal and will list on the Toronto Stock Exchange’s venture exchange from tomorrow.
CRO Spinnovation Biologics says new media analysis service will help developers answer culture scale-up questions faster and more cheaply than currently available methods.
South Africa aims to boost its pharmaceutical production sector by developing a 70-strong list of oral solid dose drugs that it will only buy from local manufacturers.
in-PharmaTechnologist presents its weekly round-up of the latest new appointments within the pharmaceutical industry including news from Centerstone, Bellicum and PhRMA.
The United States Pharmacopoeia (USP) has agreed to work with the South Korea Food and Drug Administration (KFDA) on the quality of medicines under an MOU signed this week.
Australian preclinical CRO vivoPharm has bought toxicology testing firm RMIT Drug Discovery Technologies (RDDT) and will relocated to a new Melbourne HQ.
inVentiv CEO says PharmaNet and i3 integration ‘essentially complete’ and that – while demand from individual customers can fluctuate - the combination of the two businesses is creating new opportunities.
More post-acquisition integration in the pharma excipients space this week with Ashland launching a new product line combining its own techs with coatings it bought with International Specialty Products (ISP) in 2011.
Outsourcing-Pharma presents its weekly round-up of the latest comings and goings in the pharmaceutical industry including news from RPS, INC Research and AMRI.
Almac says the adoption of ‘lean six sigma’ was the right move for its clinical technologies business, even taking higher initial training costs into account.
Cetero Research executives want bonuses if they manage to find a buyer for the ailing firm according to documents filed as part of the CRO's bankruptcy case.
